The Molecular Mechanism of the Effect of Carvacrol on Desflurane Inhalation-Induced Liver Damage in Rats
dc.authorid | Taş, Hakan Gökalp/0000-0001-5680-9544; | |
dc.authorwosid | Taş, Hakan Gökalp/HHD-2030-2022 | |
dc.authorwosid | YAZICI, GÜLCE/GYR-3499-2022 | |
dc.contributor.author | Disli, Zeliha Korkmaz | |
dc.contributor.author | Delen, Leman Acun | |
dc.contributor.author | Tas, Hakan Gokalp | |
dc.contributor.author | Kuyrukluyildiz, Ufuk | |
dc.contributor.author | Disli, Olcay Murat | |
dc.contributor.author | Yazici, Gulce Naz | |
dc.contributor.author | Coban, Abdulkadir | |
dc.date.accessioned | 2024-08-04T20:51:48Z | |
dc.date.available | 2024-08-04T20:51:48Z | |
dc.date.issued | 2022 | |
dc.department | İnönü Üniversitesi | en_US |
dc.description.abstract | The metabolite of desflurane has been linked to hepatotoxicity. Carvacrol possesses antioxidant, antibacterial, antifungal, anticancer, anti-inflammatory, and spasmolytic properties, according to research. Our goal is to demonstrate that carvacrol protects rats' livers against repeated doses of desflurane. Healthy (HG), desflurane (DS), and carvacrol + desflurane treatment (CDS) groups were formed from 18 albino male Wistar rats. A single dosage of carvacrol and 6% desflurane was given for 2 h on the 0th and 8th days. In the CDS group, the ALT and AST, MDA, TOS, NF-xB, TNF-alpha IL1 beta levels were lower compared to the DS group (p < 0.001). The tGSH,TAS levels were found to be higher in the CDS group compared to the DS group (p < 0.001). It was determined that the mean degeneration level, Kupffer cell activation and PMNL infiltration were found to be lower compared to the DS group (p < 0.05).We confirmed that carvacol can be used in the treatment of desflurane-related liver injury. | en_US |
dc.identifier.endpage | 137 | en_US |
dc.identifier.issn | 0326-2383 | |
dc.identifier.issue | 1 | en_US |
dc.identifier.scopus | 2-s2.0-85127149965 | en_US |
dc.identifier.scopusquality | Q4 | en_US |
dc.identifier.startpage | 130 | en_US |
dc.identifier.uri | https://hdl.handle.net/11616/100563 | |
dc.identifier.volume | 41 | en_US |
dc.identifier.wos | WOS:000747919200002 | en_US |
dc.identifier.wosquality | Q4 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.language.iso | en | en_US |
dc.publisher | Colegio Farmaceuticos Provincia De Buenos Aires | en_US |
dc.relation.ispartof | Latin American Journal of Pharmacy | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | antioxidant | en_US |
dc.subject | carvacrol | en_US |
dc.subject | desflurane | en_US |
dc.subject | hepatotoxicity | en_US |
dc.subject | inhalation anesthesia | en_US |
dc.title | The Molecular Mechanism of the Effect of Carvacrol on Desflurane Inhalation-Induced Liver Damage in Rats | en_US |
dc.type | Article | en_US |